These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Upregulation of acyl-CoA: cholesterol acyltransferase in chronic renal failure. Liang K; Vaziri ND Am J Physiol Endocrinol Metab; 2002 Oct; 283(4):E676-81. PubMed ID: 12217884 [TBL] [Abstract][Full Text] [Related]
30. Esculeogenin A, a new tomato sapogenol, ameliorates hyperlipidemia and atherosclerosis in ApoE-deficient mice by inhibiting ACAT. Fujiwara Y; Kiyota N; Hori M; Matsushita S; Iijima Y; Aoki K; Shibata D; Takeya M; Ikeda T; Nohara T; Nagai R Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2400-6. PubMed ID: 17872457 [TBL] [Abstract][Full Text] [Related]
31. Effects of an anti-oxidative ACAT inhibitor on apoptosis/necrosis and cholesterol accumulation under oxidative stress in THP-1 cell-derived foam cells. Miike T; Shirahase H; Jino H; Kunishiro K; Kanda M; Kurahashi K Life Sci; 2008 Jan; 82(1-2):79-84. PubMed ID: 18037448 [TBL] [Abstract][Full Text] [Related]
33. Host cell lipids control cholesteryl ester synthesis and storage in intracellular Toxoplasma. Nishikawa Y; Quittnat F; Stedman TT; Voelker DR; Choi JY; Zahn M; Yang M; Pypaert M; Joiner KA; Coppens I Cell Microbiol; 2005 Jun; 7(6):849-67. PubMed ID: 15888087 [TBL] [Abstract][Full Text] [Related]
34. Cholesterol esterification by host and parasite is essential for optimal proliferation of Toxoplasma gondii. Sonda S; Ting LM; Novak S; Kim K; Maher JJ; Farese RV; Ernst JD J Biol Chem; 2001 Sep; 276(37):34434-40. PubMed ID: 11457847 [TBL] [Abstract][Full Text] [Related]
35. Inhibition of acyl-CoA cholesterol acyltransferase by F12511 (Eflucimibe): could it be a new antiatherosclerotic therapeutic? López-Farré AJ; Sacristán D; Zamorano-León JJ; San-Martín N; Macaya C Cardiovasc Ther; 2008; 26(1):65-74. PubMed ID: 18466422 [TBL] [Abstract][Full Text] [Related]